Preferred Label : Invasive Breast Carcinoma;

NCIt synonyms : Infiltrating Carcinoma of Breast; Infiltrating Carcinoma of the Breast; Infiltrating Breast Carcinoma; Invasive Carcinoma of Breast; Invasive Carcinoma of the Breast;

NCIt related terms : Invasive Breast Cancer; infiltrating breast cancer; Invasive mammary carcinoma;

NCIt definition : A carcinoma that infiltrates the breast parenchyma. The vast majority are adenocarcinomas arising from the terminal ductal lobular unit (TDLU). Often, the invasive adenocarcinoma co-exists with ductal or lobular carcinoma in situ. It is the most common carcinoma affecting women.;

Alternative definition : NCI-GLOSS: Cancer that has spread from where it started in the breast into surrounding, healthy tissue. Most invasive breast cancers start in the ducts (tubes that carry milk from the lobules to the nipple). Invasive breast cancer can spread to other parts of the body through the blood and lymph systems.;

Neoplastic status : Malignant;

Codes from synonyms : CDR0000537695; 10006190; CDR0000538415;

Details


Main resources

You can consult :


http://www.e-cancer.fr/content/download/213527/2897775/file/Avis%20d%3Fexperts%20-%20Les%20taxanes%20dans%20le%20traitement%20des%20cancers%20du%20sein%20infiltrants%20non%20me%3Ftastatiques%20et%20conduites%20a%3F%20tenir%20pour%20la%20pre%3Fvention,%20le%20suivi%20et%20la%20gestion%20de%20certains%20effets%20inde%3Fsirables%20potentiellement%20graves%20%2816%20octobre%202017%29.pdf
2017
false
false
false
France
French
consensus
breast neoplasms
Invasive Breast Carcinoma
taxanes
antineoplastic agents
taxoids
taxoids
continuity of patient care
drug monitoring
Drug-Related side effects and adverse reactions
guidelines for drug use
drug interactions
paclitaxel
paclitaxel
neoadjuvant therapy
chemotherapy, adjuvant
enterocolitis
Chemotherapy-Induced febrile neutropenia
peripheral nervous system diseases
Chemical and Drug Induced Liver Injury
drug hypersensitivity
Paclitaxel adverse reaction (disorder)
risk factors
Drug-Related side effects and adverse reactions
antineoplastic agents
Docetaxel
Docetaxel

---
Nous contacter.
28/04/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.